- Home
- MTG vs ASND Comparison
MTG vs ASND Comparison
Compare MTG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTG
- ASND
- Stock Information
- Founded
- MTG 1957
- ASND 2006
- Country
- MTG United States
- ASND Denmark
- Employees
- MTG N/A
- ASND N/A
- Industry
- MTG Property-Casualty Insurers
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MTG Finance
- ASND Health Care
- Exchange
- MTG Nasdaq
- ASND Nasdaq
- Market Cap
- MTG 6.3B
- ASND 7.3B
- IPO Year
- MTG 1991
- ASND 2015
- Fundamental
- Price
- MTG $24.90
- ASND $126.51
- Analyst Decision
- MTG Buy
- ASND Strong Buy
- Analyst Count
- MTG 6
- ASND 13
- Target Price
- MTG $25.50
- ASND $191.77
- AVG Volume (30 Days)
- MTG 1.8M
- ASND 422.4K
- Earning Date
- MTG 11-04-2024
- ASND 11-14-2024
- Dividend Yield
- MTG 2.09%
- ASND N/A
- EPS Growth
- MTG 14.71
- ASND N/A
- EPS
- MTG 2.83
- ASND N/A
- Revenue
- MTG $1,190,244,000.00
- ASND $365,187,374.00
- Revenue This Year
- MTG N/A
- ASND $10.30
- Revenue Next Year
- MTG $3.10
- ASND $90.02
- P/E Ratio
- MTG $8.80
- ASND N/A
- Revenue Growth
- MTG 2.31
- ASND 115.54
- 52 Week Low
- MTG $17.31
- ASND $90.13
- 52 Week High
- MTG $26.53
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- MTG 49.97
- ASND 46.41
- Support Level
- MTG $24.42
- ASND $124.11
- Resistance Level
- MTG $25.09
- ASND $129.86
- Average True Range (ATR)
- MTG 0.57
- ASND 5.50
- MACD
- MTG 0.03
- ASND 0.28
- Stochastic Oscillator
- MTG 65.32
- ASND 56.59
About MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all 50 states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.